Description: AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California.
Home Page: www.anaptysbio.com
ANAB Technical Analysis
10770 Wateridge Circle
San Diego,
CA
92121-5801
United States
Phone:
858 362 6295
Officers
| Name | Title |
|---|---|
| Mr. Daniel R. Faga | Interim Pres & CEO and Director |
| Mr. Eric J. Loumeau | COO & Gen. Counsel |
| Mr. Hamza Suria M.B.A., M.Sc. | Advisory |
| Dr. Paul F. Lizzul FAAD, M.B.A., M.D., M.P.H., Ph.D. | Chief Medical Officer |
| Mr. Dennis M. Mulroy | Chief Financial Officer |
| Mr. Benjamin Stone | Sr. VP of Corp. Devel. |
| Ms. Beth Mueller | Sr. VP of HR |
| Dr. Martin Dahl Ph.D. | Sr. VP of Research |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.0048 |
| Price-to-Sales TTM: | 178.1566 |
| IPO Date: | 2017-01-26 |
| Fiscal Year End: | December |
| Full Time Employees: | 102 |